The patient’s own doctors couldn’t agree on a cause. One said asthma. Another implicated her age, then 71. A third blamed ...

Health officials said that the case is not connected to another measles case in Montgomery County, nor to a widespread ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Trevi Therapeutics (TRVI) announced topline results from its Phase 2a RIVER trial of Haduvio for the treatment of patients with RCC. Haduvio ...

Enrollment is now complete in the CORAL clinical trial of nalbuphine ER, to be marketed as Haduvio, for IPF patients with ...

US-based clinical trial technology provider Mural Health Technologies has partnered with Irish healthcare intelligence ...

A Corporate presentation is available for in-person conference attendees. About Trevi Therapeutics, Inc. Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing the ...

NEW HAVEN, Conn., Feb. 25, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduviotm (oral ...

"Chronic cough has a significant impact on IPF patients, and its persistent physical effects may worsen a patient's overall health. Current off-label treatments and antifibrotics are often ...

SMA can weaken the muscles supporting the chest wall, ultimately leading to breathing difficulties and inefficient coughing and clearance of lung secretions — which increase the risk of lung ...

This is the first study to comprehensively evaluate children with chronic cough and without a selective workup. Our study suggests that among children with chronic cough (ie, cough of > 8 weeks ...

Of those, 46 are psychiatric inpatients and two are receiving out-patient treatment while in prison. The most common charges against them related to criticism of the war. Thirteen of the people ...